Form 4: Heron Therapeutics CFO Acquires Shares via RSU Vesting

Heron Therapeutics' EVP and CFO, Ira Duarte, acquired 3,875 shares of common stock through the vesting of restricted stock units.

Summary

• Ira Duarte, Executive Vice President and Chief Financial Officer of Heron Therapeutics, Inc. (HRTX), acquired 3,875 shares of common stock.
• The acquisition occurred on January 19, 2026, through the vesting of restricted stock units (RSUs).
• Each restricted stock unit represents a contingent right to receive one share of common stock, with an exercise price of $0.
• Following this transaction, Ira Duarte beneficially owns 183,661 shares of common stock.
• Additionally, Duarte holds 30,994 derivative restricted stock units.
• The restricted stock units vest in 16 equal quarterly installments, commencing one quarter after the grant date of January 19, 2024.

Sentiment

Score: 7

Explanation: The filing indicates a routine insider acquisition of shares through RSU vesting, which is generally viewed as a neutral to slightly positive signal of management's continued stake and confidence in the company.

Positives

• An executive acquiring shares, even through RSU vesting, can signal confidence in the company's future prospects.

Stakeholder Impact

• Shareholders may interpret the executive's continued accumulation of shares, even through vesting, as a sign of ongoing commitment and alignment of interests with shareholders.

Next Steps

• Remaining restricted stock units will continue to vest in 16 equal quarterly installments, starting one quarter after the January 19, 2024 grant date.

Key Dates

Recommendation

This Form 4 filing details a routine, scheduled insider transaction (RSU vesting) and does not provide new information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. It primarily confirms an executive's continued beneficial ownership.

Keywords

Heron Therapeutics, HRTX, Insider Transaction, Form 4, Restricted Stock Units, CFO, Stock Acquisition, Beneficial Ownership